MedDRA TERM SELECTION: POINTS TO CONSIDER Release 3.1 Based on MedDRA version 5.1 ICH-Endorsed Guide for MedDRA Users Application to Adverse Drug Reac
|
|
|
- ああす やすこ
- 7 years ago
- Views:
Transcription
1 MedDRA 3.1 MedDRA V.5.1 MedDRA /
2 MedDRA TERM SELECTION: POINTS TO CONSIDER Release 3.1 Based on MedDRA version 5.1 ICH-Endorsed Guide for MedDRA Users Application to Adverse Drug Reactions / Adverse Events & Medical and Social History & Indications 12 September 2002
3 Copyright ICH Secretariat (c/o IFPMA) Copying is permitted, with reference to source, but material in this publication may not be used in any documentation or electronic media which is offered for sale, without the prior permission of the copyright owner. IFPMA 30 rue de St- Jean P.O. Box Geneva 13 Switzerland Tel: +41 (22) Fax: +41 (22) JMO
4 MedDRA LLT ICH Points to Consider : ICH Points to Consider... 19
5 1.0 ICH MedDRA 1 Points to Consider(PTC) ICH MedDRA ICH MedDRA MedDRA EU USA MSSO JMO 4.0 MedDRA V MedDRA Points to Consider MedDRA MedDRA 1.2 MedDRA 1
6 (safety signals) / ADR/AE ADR/AE ADR/AE 1.3 MedDRA Points to Consider MedDRA MedDRA MedDRA PTC MedDRA MedDRA MedDRA MedDRA (MedDRA) MedDRA Introductory Guide 1.4 ADR/AE
7 (LLT) 2.3 LLT LLT( ) ( ) MedDRA MedDRA MSSO (change request) HIV HIV viral load increased MedDRA MedDRA brittle hair Hair texture abnormal NOS Hair disorder NOS MedDRA MSSO (metastatic gallbladder cancer) MedDRA (Gallbladder cancer) NOS Metastases NOS NOS 3
8 ADR/AE, ( abdominal pain) ( increased serum amylase) (increased serum lipase) (pancreatitis) (anaphylactic reaction) (rash) (dyspnea) (hypotension) (laryngospasm) (anaphylactic reaction) (myocardial infarction) (chest pain) (dyspnea), (diaphoresis) ECG (ECG changes) (jaundice) (myocardial infarction) (jaundice) 2.6 4
9 Points to Consider MedDRA MedDRA MedDRA MedDRA SOC MedDRA MSSO MedDRA VIII (Factor deficiency) SOC SOC SOC possible myocardial infarction Myocardial infarction (chest pain) (dyspnea) (diaphoresis) (jaundice) (possible myocardial infarction) (myocardial infarction) (jaundice) (chest pain) (dyspnea) (diaphoresis) (jaundice) (possible myocardial infarction) (chest pain) (dyspnea) (diaphoresis) (jaundice) 5
10 3.1.3 pulmonary embolism (myocardial infarction) (congestive heart failure) pulmonary embolism (myocardial infarction) (congestive heart failure) : (chest pain) (cyanosis) (shortness of breath) (blood pressure decreased) (pulmonary embolism) (myocardial infarction) (congestive heart failure) (Chest pain) (Cyanosis) (Shortness of breath) (Blood pressure decreased) : (pulmonary embolism) (myocardial infarction) (congestive heart failure) (chest pain) (cyanosis) (shortness of breath) (blood pressure decreased) (Chest pain) (Cyanosis) (Shortness of breath) (Blood pressure decreased) (Pulmonary embolism) (Myocardial infarction) (Congestive heart failure) ADR/AE ADR/AE ADR/AE (death due to myocardial infarction) (Myocardial infarction) ADR/AE MedDRA : (constipation) (ruptured bowel) (peritonitis) (sepsis) (patient died) (Constipation) (Perforated bowel) (Peritonitis) (Sepsis) 6
11 3.2.3 : (a patient was found dead) (Found dead) : 1.6mEq/L (hyperkalemia with a serum potassium of 1.6 meq/l) (Potassium abnormal) 1.6mEq/L : GU (GU pain) GU (genito-urinary) (gastric ulcer) (pain) (Pain) (patient experienced every listed adverse event) (Unevaluable reaction) (arrhythmia due to atrical fibrillation) (Atrial fibrillation) (hepatic function disorder (acute hepatitis) ) 7
12 (Hepatitis acute) MedDRA (retinopathy due to diabetes) (Diabetic retinopathy) (rash with itching) (Itchy rash) (diarrhea and vomiting) (Diarrhea) (Vomiting) DIC(DIC due to sepsis) DIC (Sepsis) (wrist fracture due to fall) (Wrist fracture) (Fall) MedDRA (skin rash on face) (Rash on face) MedDRA MedDRA (skin rash on chest) (Rash) PT (skin rash on face and neck) (Skin rash) MedDRA (pneumococcal pneumonia) 8
13 (Pneumococcal pneumonia) MedDRA MedDRA (respiratory fungal infection) (Fungal infection) (respiratory fungal infection) (Respiratory infection) (respiratory fungal infection) (Fungal infection) (Respiratory infection) ADR/AE MedDRA (exacerbation of myasthenia gravis) (Myasthenia gravis aggravated) MedDRA (halitosis worsened) (Halitosis) (Condition aggravated) NOS(Disease progression NOS) (progression of Alzheimer s disease) (Alzheimer s disease) NOS(Disease progression NOS) (aggravation of jaundice) (Jaundice) (Condition aggravated) 9
14 3.8 MedDRA (congenital) MedDRA Version SOC (congenital heart disease) (child born with heart disease) NOS(Congenital heart disease NOS) MedDRA (hemangioma) PT ( Haemangioma acquired ) (Hemangioma)) (cholangiectasis) (Cholangiectasis acquired) 3.9 ADR/AE SOC (patient had gallbladder surgery) NOS(Gallbladder operation NOS) (patient had tonsillectomy in childhood) (Tonsillectomy) ADR/AE 10
15 (liver tranlplantation due to liver failure) (Liver failure) (Liver failure) (Liver transplant) (surgery for bleeding gastric ulcer) (Bleeding gastric ulcer) (Bleeding gastric ulcer) NOS(Gastric ulcer surgery) 3.10 SOC (increased) (decreased) (abnormal) (normal) hyper hypo SOC SOC SOC SOC SOC b (cardiac output) (cardiac output) ADR/AE (hypoglycemia) (Hypoglycemia) (Hypoglycemia) SOC (decreased glucose) (Glucose decreased) (Glucose decreased) SOC mg/dl(glucose 40 mg/dl) (Glucose low) (his glucose was 40) (Glucose abnormal) 11
16 K7.0mmol/L (elevated potassium, K7.0 mmol/l and hyperkalemia) (Hyperkalemia) mmol/L (alopecia, rash, and elevated potassium 7.0 mmol/l) (Alopecia) (Rash) (Potassium increased) (abnormal liver function tests) (Abnormal liver function tests) SGPT SGOT LDH (increased alkaline phosphatase, increased SGPT, increased SGOT, and elevated LDH) 4 (Liver function tests raised) ADR/AE (Drug maladministration) (Medication error) (medication was given intravenously instead of intramuscularly) (Wrong route of administration) (nurse splashed an injectable drug in her eye) (Inadvertent exposure to drug) (Drug exposure via breast milk) ( No adverse effect) 3.15 (medication was given intravenously 12
17 instead of intramuscularly without sequelae) (Wrong route of administration) (No adverse effect) MedDRA Overdose Toxicity Poisoning HLT (Poisoning and toxicity) MedDRA Version 5.0 (overdose of pills) (Overdose) (Stomach upset from study drug overdose) (Stomach upset) (Overdose) (Overdose) (No adverse effect) 3.13 MedDRA (Torsade de pointes with suspected drug interaction) (Torsade de pointes) (Drug interaction) (Patient was started on an anit-seizure and heart medication and developed syncope) (Syncope) (Patient was already on anti-seizure medication and was started on a heart medication and anti-seuzure medicaiton levels increased) 13
18 (Drug level increased) 3.14 (No adverse effect) ADR/AE MedDRA (Normal baby) (Normal electrocardiogram) (Sinus rhythm) 3.15 ADR/AE (a bold patient was pleased that he grew hair while on an antihypertentive) (Benefit unexpected) (Hair growth increased) 3.16 ADR/AE MedDRA (antibiotic didn t work) (Lack of drug effect) (patient took drug, her headache didn t go away) (Drug ineffective) (an epilectic 14
19 patient took an anti-convulsant, but the seizures continued unchanged) (Lack of drug effect) HIV AIDS (AIDS patient taking anti-hiv drug died) (Lack of drug effect) Increased Decreased Prolonged A (patient had increased effect from drug A) (Increased drug effect) A (patient had decreased effect from drug A) (Drug effect decreased) A (patient had prolonged effect from drug A) (Drug effect prolonged) 3.17 SOC SOC ADR/AE ADR/AE SOC (patient was abusing an analgesic) (Analgesic abuse) SOC MedDRA SOC (Disorder) SOC ADR/AE Social Circumstances SOC ( Alcoholic ) Disorder SOC (Alcoholism) (Drug addict) (Drug addiciton) 3.18 MedDRA 15
20 (history of gastrointestinal bleed and hysterectomy) (Gastrointestinal bleed) (Hysterectomy) (patient is a cigarette smoker with coronary artery disease) (Cigarette smoker) (Coronary artery disease) [ hypertension ] Hypertension hypertensive ] chemotherapy for breast cancer 16
21 (Breast cancer) (medication for gastrointestinal problem) (Gastrointestinal disorder therapy) ( Gastrointestinal disorder) MedDRA a patient had received chemotherapy NOS Chemotherapy NOS Prevention and Prophylaxis MedDRA prevention prophylaxis (arrhythmia prophylaxis) (arrhythmia prophylaxis) prevention of migraine (Migraine prophylaxis) (prevention of miscarriage) (Miscarriage) (prevention of miscarriage) (Prevention) contrast agent for angiogram (Angiogram NOS) contrast agent for coronary angiogram ( Coronary angiogram) (induction of anesthesia) (Induction of anesthesia) SOC
22 testosterone replacement therapy (Androgen replacement therapy) thyroid replacement therapy (Thyroxine therapy) prenatal vitamin (Vitamin supplementation) (Drug use for unknown indication) 1 MedDRA MSSO JMO 2 ADR/AE ICH CIOMS 3 (Drug) 18
23 ICH Points to Consider : Rapporteur: Margaret M. Westland Japan: Ministry of Health, Labour and Welfare: Kaori Nomura Japan Pharmaceutical Manufactures Association Yasuo Sakurai Japanese Maintenance Organization Reiji Tezuka Yuki Tada European Union: Commission of the European Communities Dolores Montero European Federation of Pharmaceutical Industries Associations Barry Hammond Reinhard Fescharek Canada: Health Canada Bill Wilson United States: US Food and Drug Administration Andrea Feight Toni Piazza-Hepp Pharmaceutical Research and Manufacturers of America Susan M. Lorenski MedDRA MSSO JoAnn Medbery 4.2 ICH Points to Consider Japan: Ministry of Health, Labour and Welfare Tamaki Fushimi 19
24 Kazuhiro Kemmotsu Emiko Kondo Kemji Kuramochi Takashi Yasukawa Japan Pharmaceutical Manufactures Association Akemi Ishikawa Satoru Mori Canada: Health Canada Heather Morrison United States: US Food and Drug Administration Miles Braun Brad Leissa Pharmaceutical Research and Manufacturers of America David Goldsmith Sidney Kahn 20
MedDRA TERM SELECTION: POINTS TO CONSIDER Release 3. Based on MedDRA version.1 ICH-Endorsed Guide for MedDRA Users Application to Adverse Drug Reactio
MedDRA R 3.5 MedDRA Version 8.1 MedDRA / 2005 11 7 MedDRA TERM SELECTION: POINTS TO CONSIDER Release 3. Based on MedDRA version.1 ICH-Endorsed Guide for MedDRA Users Application to Adverse Drug Reactions
DatRetPrePTC_R1.4_J.doc
MedDRA Release 1.4 MedDRA 10.1 ICH MedDRA 2007 912 MedDRA DATA RETRIEVAL AND PRESENTATION: POINTS TO CONSIDER Release 1.4 Based on MedDRA Version 10.1 ICH-Endorsed Guide for MedDRA Users on Data Output
Microsoft Word - TermSelPTC_R4.6SoC_sep2013 Japanese revise.docx
Release 4.5 から 4.6 への主な変更点 MedDRA 用語選択 : 考慮事項 公表版 4.6 (MedDRA Version 16.1 対応 ) 2013 年 10 月 1 日 本資料は MedDRA 用語選択 : 考慮事項 の Release 4.5 から Release 4.6 への変更点を示したものである 文書全体 1) スペル 句読点等の修正 2) 参照する MedDRA をバージョン
MedDRA 用語選択 : 考慮事項 公表版 3.14 (MedDRA Version 13.0 対応 ) ICH 活動で作成された MedDRA ユーザーのためのガイド 医薬品副作用 / 有害事象 および 医学的 社会的背景 適応症に対する適用 2010 年 4 月 1 日
MedDRA 用語選択 : 考慮事項 公表版 3.14 (MedDRA Version 13.0 対応 ) ICH 活動で作成された MedDRA ユーザーのためのガイド 医薬品副作用 / 有害事象 および 医学的 社会的背景 適応症に対する適用 2010 年 4 月 1 日 MedDRA TERM SELECTION: POINTS TO CONSIDER Release 3.14 Based on
ｽﾗｲﾄﾞ ﾀｲﾄﾙなし
MedDRA 3 CRC 2004 4 24 NPO DSRU Japan kubotape-tky@umin.ac.jp MedDRA Medical Dictionary for Regulatory Activities Terminology MedDRA ICH: International Conference on Harmonisation SOC HLGT HLT PT LLT MedDRA
日本化学療法学会雑誌第61巻第4号
μ μ μ μ μ μ Key words I β μ Sex Age (years) Height (cm) Evaluation items Table1.Characteristics of patients 1. mg/kg/day (n14) 2.5 mg/kg/day (n9) 5. mg/kg/day (n9) Total (n32) male 12 8 7 27 female 2 1
JIPAD2015.pptx
ICU 機能評価委員会報告 JIPAD update 2015 - 過去 現在 そして未来へ - 内野滋彦 東京慈恵会医科大学附属病院集中治療部 x 日本集中治療医学会学術集会 COI 開示 筆頭発表者 : 内野滋彦 1 役員 顧問職等の報酬 * 無 2 株式の利益 * ( または株式の5% 以上 ) 無 3 特許権使用料など * 無 4 講演料など * 無 5 原稿料など * 無 6 研究費 助成金など
Microsoft PowerPoint - LITA-noreflow_English.pptx
A case of no-reflow phenomenon during PCI to LIMA graft Iwatsuki-Minami hospital, Saitama, Japan Koichi Sano, Masaki Tsukagoshi, Yasunari Ueno, Seiichi Fukuda, Takayoshi Sato, Yasuyuki Maruyama 77 y.o.
untitled
CTCAE v3.0 JCOG/JSCO v1.0 Instructions and Guidelines for Japanese CTCAE v3.0 by JCOG and JSCO JCOG JCOG JCOG JCOG 2004 5 13 2004 7 1 2004 10 1 2004 10 27 JCOG http://www.jcog.jpjcog 0. 0.1. NCI Common
VOL.39 S-3
VOL.39 S-3 CHEMOTHERAPY SEPT.1991 Table 1. Background of characteristics and allocation of 5 healthy male volunteers in a multiple-dose study on panipenem/betamipron Day 1 Fig. 1. Schedule of multiple-dose
日本化学療法学会雑誌第65巻第4号
Mycoplasma pneumoniae M. pneumoniae M. pneumoniae M. pneumoniae M. pneumoniae M. pneumoniae Key words Mycoplasma pneumoniae Mycoplasma pneumoniae M. pneumoniae I M. pneumoniae M. pneumoniae M. pneumoniae
untitled
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 20021016 17 18 1018 19 20 21 22 23 24 25 1 11 ICHMedDRA/ J ver. 10.0Preferred Term 26 27 http://www.info.pmda.go.jp/ http://www.pmda.go.jp/index.html ICH MedDRA/Jver.11.1
2014-sougou_all.pdf
37 Ministry of Health, Labour and Welfare 2014 38 Ministry of Health, Labour and Welfare 2014 39 Ministry of Health, Labour and Welfare 2014 40 Ministry of Health, Labour and Welfare 2014 Q1 A1 Q2 A2 Q3
日本化学療法学会雑誌第60巻第4号
Streptococcus pneumoniae Haemophilus influenzae S. pneumoniae H. influenzae Key words β Streptococcus pneumoniae Haemophilus influenzae S. pneumoniae H. influenzae μ μ S. pneumoniae H. influenzae S. pneumoniae
日本職業・災害医学会会誌第54巻第6号
Reprint request: A CASE OF PRESENTED VARIOUS FUNCTIONAL DISTURBANCES AFTER AN INJURY Taketoshi NOGAKI, Nobusuke HOUCHI, Tomoko SUGIUCHI, Naohiko WATANABE and Hiroyuki ZUSHO Department of Otolaryngology,
Fig. 1 A: Effects of intramuscular injection of glucagon on the blood glucose levels (changes from basal, ƒ BG) as compared with effects of scopolamin
Fig. 1 A: Effects of intramuscular injection of glucagon on the blood glucose levels (changes from basal, ƒ BG) as compared with effects of scopolamine butylbromide during upper gastrointestinal endoscopy.
Copyright 2001, 1999, 1997, 1995, 1993, 1991, 1990 by The McGraw-Hill Companies, Inc. All rights reserved. Printed in the United States of America. Except as permitted under the United States Copyright
第６１巻５・６号（１２月号）／特集１頁目（本刷）
Special Issue 1Sudden cardiac death symposium in Tokushima Special Issue 2How to do for your health? Reviews Original Epidemiologic problems of sudden death of school children in Tokushima Prefecture
基本操作ガイド
HT7-0199-000-V.5.0 1. 2. 3. 4. 5. 6. 7. 8. 9. Copyright 2004 CANON INC. ALL RIGHTS RESERVED 1 2 3 1 1 2 3 4 1 2 1 2 3 1 2 3 1 2 3 1 2 3 4 1 2 3 4 1 2 3 4 5 AB AB Step 1 Step
老人性不整脈
資料 : QOL CHADS NOAC はじめに common disease 高齢者の不整脈の頻度, AF AVB RBBB LBBB Cardiovascular Health Study, 137 表 1 Outpatient Atarashi Cardiovascular Health Study Monolio No F M Ectopic beats Supraventricular.
操作ガイド（本体操作編）
J QT5-0571-V03 1 ...5...10...11...11...11...12...12...15...21...21...22...25...27...28...33...37...40...47...48...54...60...64...64...68...69...70...70...71...72...73...74...75...76...77 2 ...79...79...80...81...82...83...95...98
11_渡辺_紀要_2007
56 1 19 Bull. Nara Univ. Educ., Vol. 56, No.1 (Cult. & Soc.), 2007 115 19 Why is Kidney Dysfunction Caused by Cadmium (Cadmium Nephropathy) not Officially Recognized as a Pollution-related Disease by the
_’£”R‡Ù‡©
29 31 38 2008 31 1) 2) 2) 3) 2) 1) 2008 302008 12 Activities of Daily Living ADL ADL 42 ADL ADL 1990 QOL Quality of Life QOL 1 QOL // 2 Activity of Daily Living ADL Performance Status PS ADL 3 1) 2) 3)
Table 1 Profiles of 28 patients with Legionella pneumonia in Japan, 1980-1990 a) Y Taguchi, personal communication b) M. Hayase, personal communicatio
Key words: Legionella pneumonia, culture-positive, Japanese patients Legionella (L. pneumophila (L. micdadei, L. bozemanii, Table 1 Profiles of 28 patients with Legionella pneumonia in Japan, 1980-1990
操作ガイド（本体操作編）
J-1 QT5-0681-V02 1 m a b c d e f l kj i h g a b c d e f g h i j k l m n n o o s p q r p q r s w t u v x y z t u v w x y z a bc d e f g q p o n m l k j i h a b c d e f g h i j k l {}[] {}[] m n
Copyright 2002-2003 SATO International All rights reserved. http://www.satoworldwide.com/ This software is based in part on the work of the Independen
SATO Label Gallery SATO International Pte Ltd Version : BSI-021227-01 Copyright 2002-2003 SATO International All rights reserved. http://www.satoworldwide.com/ This software is based in part on the work
STUDIES ON THE RELATION BETWEEN LATE DUMPING SYNDROME AND GLUCAGON RESPONCES TO GLUCOSE Taisuke MATSUI The First Department of Surgery, Nara Medical U
STUDIES ON THE RELATION BETWEEN LATE DUMPING SYNDROME AND GLUCAGON RESPONCES TO GLUCOSE Taisuke MATSUI The First Department of Surgery, Nara Medical University, Kashihara (Director: Prof. H. Nakano) This
総 説 6 6 PIMs P S J 7
2018 10 1-6 総 説 2018 P S J 1 2018 10 7-13 総 説 6 6 PIMs P S J 7 2018 10 19-29 誌上シンポジウム JASDS DSM 1997 2012 15 DSM DSSP JASDS DSM DSSP P S J 19 2018 10 30-34 誌上シンポジウム ADME 30 Pharmacy Society of Japan 2018
鷲谷先生寄贈リスト.PDF
1939 1946 1958 1961 1980 1947 1953 1962 1913 2 2 19 2003 15 11 27 1935 10 3 1946 21 10 1947 22 4 1950 25 4 1958 33 4 1961 36 5 1980 55 3 4 36 5 Present Conditions of the Child Welfare Work in Japan., 1920
Fig.1 Case 1,E.H.Clinical Course of Campylobacter Meningitis Table 1 Case 1.E.H.
Key words: Campylobacter fetus,meningitis Fig.1 Case 1,E.H.Clinical Course of Campylobacter Meningitis Table 1 Case 1.E.H. 273 昭 和61年3月20日 Table 2 Case 2.T.N. Fig.3 Case2,T.N.Clinical Campylobacter Fig.2
A Nutritional Study of Anemia in Pregnancy Hematologic Characteristics in Pregnancy (Part 1) Keizo Shiraki, Fumiko Hisaoka Department of Nutrition, Sc
A Nutritional Study of Anemia in Pregnancy Hematologic Characteristics in Pregnancy (Part 1) Keizo Shiraki, Fumiko Hisaoka Department of Nutrition, School of Medicine, Tokushima University, Tokushima Fetal
スライド 1
1 2006 msv 2 2011 3 CT 2011 10mSv 10 40mSv 4 2012 217mSv 5 (CT) 2012 50 60mSv 6 2012 510mSv BRCA25 310 10mSv3% BRCA60-280% 3 5m Sv 1m Sv 12% . http://www.rea.or.jp/ire/pdf/report4.pdf 1.10 20 SMR 1.00
Hirosaki University Repository 妊 娠 可 能 てんかん 女 性 の 治 療 管 理 基 準 設 定 に 関 する 研 Title 究 Author(s) 兼 子, 直 Citation てんかん 治 療 研 究 振 興 財 団 研 究 年 報. 4, 1992, p.24-35 Issue Date 1992 URL http://hdl.handle.net/10129/1905
1) University Group Diabetes Program: A study of hypoglycemic agents on vascular complica- in patients with adult-onset tions diabetes. I. Design, methods and baseline results. Diabetes 19 (suppl. 2):
P.1~18
JCM Copyright 2011 Japanese by JCM Copyright 2008 bymelvin W Wong Published by ARMOUR Publishing Pte Ltd Kent Ridge Post Office P.O.Box 1193,Singapore 911107 Email: mail@armourpublishing.com Website: www.armourpublising.com
FA
29 28 15 1985 1993 The process of the labor negotiations of the Japan Professional Baseball Players Association, 1985 1993 ABE Takeru Graduate School of Social Science, Hitotsubashi University Abstract
基本操作ガイド
HT7-0022-000-V.4.0 Copyright 2004 CANON INC. ALL RIGHTS RESERVED 1 2 3 1 2 3 1 2 3 1 2 3 1 2 3 4 1 1 2 3 4 5 1 2 1 2 3 1 2 3 1 2 3 1 2 3 4 1 2 3 4 1 2 3 4 5 6 1 2 3 4 5 6 7 1 2 3 4
1) Delbet P: Retrocissement du choledoque. Cholecysto-duodenostomie. Bull Mem Soc Nat Chir 50: 1144-1146, 1924 2) Wiesner RH, LaRusso NF: Clinicopathologic Features of the Syndrome of Primary Sclerosing
Medical Journal of Aizawa Hospital Medical Journal of Aizawa Hospital Vol. 7 (2009) Key words Use of food wrap or perforated polyethylene film as non-adherent dressing makes wound dressing simple
43 + +* / +3+0,, 22*,, ++..0/ / 1/. / / + /* *,* +* *.* /* 0 +0 2*,/./ +3+,. + : / 3 / +** +**, // /. /+ /+ + * * + +2 +2 +3,* 3 3 ++ +, 0.. /3 : +/,.
42 * :. +, / /0/ ha, +. 2, 2ha. + : :, / /0/ +3,2. 2 / * 43 + +* / +3+0,, 22*,, ++..0/ / 1/. / / + /* *,* +* *.* /* 0 +0 2*,/./ +3+,. + : / 3 / +** +**, // /. /+ /+ + * * + +2 +2 +3,* 3 3 ++ +, 0.. /3
BUN, CRP K mg/ cm, 49.6 kg, BMI /72 mmhg, 92/ Hb 6.7 g/dl PT-INR CT 1 MRI 2a, b T1 T2 T1 MRI
20 2 2015 1 2 3 85 K CT Abstract A case of renal subcapsular hematoma resulting from trigger point injection under excessive effect of anticoagulant YAMANE Tateki, UMEDA Akira and SHIMAO Hitoshi An 85-year-old
”Лï−wŁfl‰IŠv‚æ89“ƒ/‚qfic“NŸH
March Servio P KURATA YASUMICHI, A Consideration on Change of Welfare Institutions for the Aged through the History of Japan JAPAN JOURNAL OF SOCIAL SERVICES, MAY, NUMBERJAPANESE SOCIETY FOR THE STUDY
小児感染免疫第25巻第2号
Vol. 25No. 2145 1,2 1 1 1 1 2 2 2 TFLX 9 TFLX 450 mg16.6 mgkg TFLX 30 kg TFLX 2009 10 TFLX 1 1 2 3,4 TFLX 9 22 6 18 19 TFLX 450 mg150 mg 1 1 1 3 16.6 mgkg 20 20 0 21 3 135.0 cm0.1 S.D. 27.0 kg0.8 S.D.
Core Ethics Vol. : - NICU : : - A B C D
Core Ethics Vol.,NMR...... Core Ethics Vol. : - NICU : : - A B C D b: Duff and Campbell A B C: D : a B C b Core Ethics Vol. : -, : C D :.. D.. bd D CD AB CD : Duff C b C B : Core Ethics Vol. C D B A D
2001 2003 2005 2006 2007 2008
2001 2003 2005 2006 2007 2008 60 etc. http://nosmoke.hp.infoseek.co.jp/yuugaibussitu.htm http://nosmoke.hp.infoseek.co.jp/yuugaibussitu.htm 23.5% 2.8% 2.8% 3.4% 30.3% 9.9% 11.5% 15.8% AAN 65
05 ’łŒì†E„³›i†E‘tfiú
Child abuse and multiple problems in the process of family functional reunification concerning the Child Care Institution Kei Kanno Takuro Motonaga Takashi Kasuga Child raising environment has changed
慢性膵炎
- - 121 , g CCK g g - kgkcal kgkcal - g,,, - G.I.Res ; 10 : - ; 13 : - ; 22 : - Meier RF, Beglinger C. Nutrition in pancreatic diseases. Best Pract Res Clin Gastroenterol ; 20 : - Pfutzer RH, Schneider
- 1 -
- 1 - - 2 - - 3 - - 4 - - 5 - - 6 - - 7 - - 8 - - 9 - - 10 - - 11 - - 12 - - 13 - - 14 - - 15 - 1 2 1-16 - 2 3 4 5 6 7-17 - 1 2 1 2 3 4-18 - 1 2 3 4 1 2-19 - 1 2 3 1 2-20 - 3 4 5 6 7 1-21 - 1 2 3 4-22
CHEMOTHERAPY JUNE 1993 Table 1. Background of patients in pharmacokinetic study
CHEMOTHERAPY JUNE 1993 Table 1. Background of patients in pharmacokinetic study VOL. 41 S 1 Table 2. Levels (Đg/ml or Đg/g) of S-1006 in serum, bile, and tissue (gallbladder) after oral administration
インターネット接続ガイド v110
1 2 1 2 3 3 4 5 6 4 7 8 5 1 2 3 6 4 5 6 7 7 8 8 9 9 10 11 12 10 13 14 11 1 2 12 3 4 13 5 6 7 8 14 1 2 3 4 < > 15 5 6 16 7 8 9 10 17 18 1 2 3 19 1 2 3 4 20 U.R.G., Pro Audio & Digital Musical Instrument
Core Ethics Vol. Sex Reassignment Surgery SRS SRS GID GID SRS GID GID GID GID GID QOL QOL QOL -- QOL
Core Ethics Vol. MTF Gender Identity Disorder GID GID GID GID QOL GID QOL QOL GID QOL GID QOL QOL QOL GID QOL Gender Identity Disorder QOL GID Core Ethics Vol. Sex Reassignment Surgery SRS SRS GID GID
28 1 1a 1b 2 MRI T2 3 CT C3 N95 N95 6ml 90
2015 28 1 89 93 CT C3 Tb PCR XP WBC 7 600/mm 3 CRP 4 08mg/dl MRI MRI CT MRI WBC 9 700/mm 3 CRP 6 09mg/dl CT C3 C2 C7 low density area CT 89 28 1 1a 1b 2 MRI T2 3 CT C3 N95 N95 6ml 90 28 1 4 CT C2 C7 low
Reviews Original Case reports 0.2 0.5 1.0 2.0 0.77 0.64 0.67 0.56 0.81 1.02 1.01 1.14 USA HIP Sweden Malmö Östergötland Kopparberg Stockholm Gothenburg UK Edinburgh Canada NBSS-1 RR=0.82 (0.72-0.95)
原著・報告・記録（４４行）／Ｐ２６１～２７４＿報告 肝移植症例登録
261 Liver Transplantation in Japan Registry by the Japanese Liver Transplantation Society The Japanese Liver Transplantation Society Summary As of December 31, 2013, a total of 7,474 liver transplants
特集・総説・報告（４４行）／Ｐ０４５－０５５＿報告 日本肝移植研究会
45 Liver Transplantation in Japan in 2006 Part 2 Registry by the The Summary Four thousand three hundred thirty liver transplants have been performed as of December 31, 2006 in 59 institutions in Japan.
Bead Instructions First, locate the acupressure point you wish to stimulate. Next, remove a plastic bead from the bag. Remove the backing from the adh
icewave Instructions Bead Instructions First, locate the acupressure point you wish to stimulate. Next, remove a plastic bead from the bag. Remove the backing from the adhesive plastic patch included.
原著・報告・記録（４４行）／Ｐ１５６～１６９＿報告 肝移植症例登録
156 Vol. 50, No. 23 Liver Transplantation in Japan Registry by the Japanese Liver Transplantation Society The Japanese Liver Transplantation Society Summary As of December 31, 2014, a total of 7,937 liver
Clinical Observation and Etiological Aspect on the Thrombocytopenic Purpura after Rubella Toyoji SODA, Masashi KAWANO, Toshihiko KATO*, and Takeshi SH
Clinical Observation and Etiological Aspect on the Thrombocytopenic Purpura after Rubella Toyoji SODA, Masashi KAWANO, Toshihiko KATO*, and Takeshi SHIGEMATSU**, Rubella is an acute viral infectious disease
小児感染免疫第29巻第2号
小児感染免疫 Vol. 29 No. 2 153 症例報告 1 1 1 1 1 1 11 2 15C 14 17 細菌性髄膜炎は, 肺炎球菌, インフルエンザ菌 b 型ワクチン導入により減少傾向であるが, 現在でも予後不良な疾患である. 先天性内耳奇形では, 細菌性髄膜炎を発症することがあることが知られているが 1,2), 細菌性髄膜炎を発症したワクチン未接種の先天性内耳奇形の 1 例を経験したため報告する.
04_学術.indd
Arts and Sciences About a Human Error prevention countermeasure based on Human Factors and Cognitive Psychology. 30178 Key words: Human Factors, Ergonomics, Cognitive Psychology, Risk management, Human
2014Vol.63No.4p.383393 Thermal environment for health and safety Hirohumi HAYAMA Masaya SAITO Haruka MIKAMI Faculty of Engineering, Hokkaido University School of Design, Sapporo City University Graduate
, PDD ASD p.,.,..,..,.,..,.,..,.,.,.,, 146
Study on the System of the Chinese Autistic in Japan Xiaotong Ro abstract This study note is mainly introduced the research of China s autistic child treatment in Japan. There is not very much research
VOL. 36 S-3 CHEMOTHERAPY 437
VOL. 36 S-3 CHEMOTHERAPY 437 438 CHEMOTHERAPY JULY 1988 Fig. 1 Contractile response of gastrointestinal tract to intravenous administration of saline and EM in interdigestive state in dogs (a) : Saline,
Experimental and Clinical Studies of Pregnant Hypertension Takashi SHIMAZU Department of Obstetrics and Gynecology, Osaka City University Medical Scho
Experimental and Clinical Studies of Pregnant Hypertension Takashi SHIMAZU Department of Obstetrics and Gynecology, Osaka City University Medical School While the problem of late pregnant hypertension
Microsoft Word - 「黄砂とその健康影響について」小冊子180323版
...1...1...1...2...4...4...4...6...7...7...7...7...8...8...9...9...10... 11... 11... 11... 11...12...12...13...16...18...20 1 1-1 1-2 1 1 km 24.5 m/s 10 50 m 1 1-3 μm 1-4 1-5 2 8 http://www.jma-net.go.jp/sat/himawari/obsimg/image_dust.html
The research,consciousness of the mother who used temporary child care at the day nursery MATSUOKA Tomoko, SAKURADANI Mariko Research for the mother who has the experience which temporary child care was
untitled
CONTENTS 01 02-03 04-05 06-07 09 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 48-49 50-51 52 01 02 Mishima,Michiaki 03 04 05 06 07 09 10 11
スライド 1
医薬品副作用報告 中部ろうさい病院薬剤部 2016 年 4 月 1 日 1 中部ろうさい病院副作用報告の書式について 下記ダウンロードページにアクセスしていただき 必要なファイルをダウンロードしてください 書式のファイルは 副作用報告 のリンク先のページに置いてあります ダウンロードページURL http://www.chubuh.johas.go.jp/clinicaltrial/database/
25 Removal of the fricative sounds that occur in the electronic stethoscope
25 Removal of the fricative sounds that occur in the electronic stethoscope 1140311 2014 3 7 ,.,.,.,.,.,.,.,,.,.,.,.,,. i Abstract Removal of the fricative sounds that occur in the electronic stethoscope
2
2 3 4 5 6 7 8 9 1 2 3 4 5 10 11 12 1 2 1 2 1 2 13 14 3 17 15 1 2 3 D Usefulness of Tc-99m MIBI SPECT in predicting multidrug resistance gene expression level in non-small cell lung cancer a preliminary
Core Ethics Vol. : - : : : -
Core Ethics Vol... : : : DC Core Ethics Vol. : - : : : - ............ Core Ethics Vol. : : : : :...... : Core Ethics Vol. : .. : : : : Core Ethics Vol. http:// www.psy-jinken-osaka.org/?page_id= : - -
<95DB8C9288E397C389C88A E696E6462>
2011 Vol.60 No.2 p.138 147 Performance of the Japanese long-term care benefit: An International comparison based on OECD health data Mie MORIKAWA[1] Takako TSUTSUI[2] [1]National Institute of Public Health,
エレクトーンのお客様向けiPhone/iPad接続マニュアル
/ JA 1 2 3 4 USB TO DEVICE USB TO DEVICE USB TO DEVICE 5 USB TO HOST USB TO HOST USB TO HOST i-ux1 6 7 i-ux1 USB TO HOST i-mx1 OUT IN IN OUT OUT IN OUT IN i-mx1 OUT IN IN OUT OUT IN OUT IN USB TO DEVICE
Web Stamps 96 KJ Stamps Web Vol 8, No 1, 2004
The Journal of the Japan Academy of Nursing Administration and Policies Vol 8, No 1, pp 43 _ 57, 2004 The Literature Review of the Japanese Nurses Job Satisfaction Research Which the Stamps-Ozaki Scale
Microsoft Word - DatRetPTC_R3.4SoC_sep2012 Japanese.doc
Release 3.3 から 3.4 への主な変更点 MedDRA データ検索及び提示 : 考慮事項公表版 3.4 (MedDRA バージョン 15.1 対応 ) 2012 年 10 月 1 日 以下に MedDRA データ検索及び提示 : 考慮事項 のリリース 3.3 から 3.4 への間での変更点を示す 文書全体における変更点 全般的なスペル 句読点 文字の間隔 図表番号およびフォーマットのエラーの修正
rectomy as the subjects of study, urinary steroid hormones were measured, and simultaneously the enzyme work and enzyme pattern related to the steroid metabolism, as proposed by Yoshida of our laboratory,
VOL. 17 NO. 7 CHEMOTHERAPY 1305 1) W. BRumFirr et al. : Clinical and laboratory studies with carbenicillin. Lancet 1: 1289~ 1293, 1967 2) E. T. KNUDSEN et al. : A new semisynthetic penicillin active against
LWW EJ on Ovid LWW Ovid Online (Ovid Web Gateway) Ovid Online LWW tutorial Ovid Online Refresh Ovid Online LWW Ovid Medline, Cinahl, EBMR, Ovid
LWW EJ on Ovid Tutorial For gateway refresh version June 2005 Ovid Technologies Japan Office japan@ovid.com Visit our homepage at http://www.ovid.jp/site/index.html for more Japanese documents and latest
iPhone/iPad接続マニュアル
/ JA 2 3 USB 4 USB USB i-ux1 USB i-ux1 5 6 i-mx1 THRU i-mx1 THRU 7 USB THRU 1 2 3 4 1 2 3 4 5 8 1 1 9 2 1 2 10 1 2 2 6 7 11 1 2 3 4 5 6 7 8 12 1 2 3 4 5 6 13 14 15 WPA Supplicant Copyright 2003-2009, Jouni
Therapy for Asthenopia in Cases of Convergence Insufficiency Hiroko TAKASAKI, C.O.J., Nobuko INAGAMI, C.O.J., and Kayoko TAKENAWA, C.O.J.. Orthoptic c
Therapy for Asthenopia in Cases of Convergence Insufficiency Hiroko TAKASAKI, C.O.J., Nobuko INAGAMI, C.O.J., and Kayoko TAKENAWA, C.O.J.. Orthoptic clinic, Department of Ophthalmology, (Director: Prof
The Journal of the Japan Academy of Nursing Administration and Policies Vol 7, No 2, pp 19 _ 30, 2004 Survey on Counseling Services Performed by Nursi
The Journal of the Japan Academy of Nursing Administration and Policies Vol 7, No 2, pp 19 _ 30, 2004 Survey on Counseling Services Performed by Nursing Professionals for Diabetic Outpatients Not Using
VOL. 21 NO. 2 CHEMOTHERAPY 395
394 CHEMOTHERAPY MAR. 1973 VOL. 21 NO. 2 CHEMOTHERAPY 395 396 CHEMOTHERAPY MAR. 1973 VOL. 21 NO. 2 CHEMOTHERAPY 397 398 CHEMOTHERAPY MAR. 1973 VOL. 2 1 NO. 2 CHEMOTHERAPY 399 400 CHEMOTHERAPY MAR. 1973
220 28;29) 30 35) 26;27) % 8.0% 9 36) 8) 14) 37) O O 13 2 E S % % 2 6 1fl 2fl 3fl 3 4
Vol. 12 No. 2 2002 219 239 Λ1 Λ1 729 1 2 29 4 3 4 5 1) 2) 3) 4 6) 7 27) Λ1 701-0193 288 219 220 28;29) 30 35) 26;27) 0 6 7 12 13 18 59.9% 8.0% 9 36) 8) 14) 37) 1 1 1 13 6 7 O O 13 2 E S 1 1 17 0 6 1 585
Bodenheimer, Thomas S., and Kevin Grumbach (1998) Understanding Health Policy: A Clinical Approach, 2nd ed. Appleton & Lange. The Present State of Managed Care and the Feasibility of its Application to
202
201 Presenteeism 202 203 204 Table 1. Name Elements of Work Productivity Targeted Populations Measurement items of Presenteeism (Number of Items) Reliability Validity α α 205 α ä 206 Table 2. Factors of
JAPANESE SHIP-OWNERS AND WORLD BULK MARKET BETWEEN THE TWO WORLD WARS Mariko Tatsuki Keisen University After World War I, Japanese shipping suffered for a long time from an excess of tonnage and severe
MIDI_IO.book
MIDI I/O t Copyright This guide is copyrighted 2002 by Digidesign, a division of Avid Technology, Inc. (hereafter Digidesign ), with all rights reserved. Under copyright laws, this guide may not be duplicated
_念3）医療2009_夏.indd
Evaluation of the Social Benefits of the Regional Medical System Based on Land Price Information -A Hedonic Valuation of the Sense of Relief Provided by Health Care Facilities- Takuma Sugahara Ph.D. Abstract
LWW EJ on Ovid LWW Ovid Online (Ovid Web Gateway) Ovid Online LWW tutorial Ovid Online Refresh Ovid Online LWW Ovid Medline, Cinahl, EBMR, Ovid
LWW EJ on Ovid Tutorial For Kagawa University Sep 2005 Ovid Technologies Japan Office japan@ovid.com Visit our homepage at http://www.ovid.jp/site/index.html for more Japanese documents and latest news.
Fig. 2 Body weight curves rats treated orally with DL-8280 for 4 weeks
Fig. 1 Chemical structure DL-8280 Fig. 2 Body weight curves rats treated orally with DL-8280 for 4 weeks Fig. 3 Food consumption in rats treated orally with DL-8280 for 4 weeks Fig. 4 Water consumption
The Change of Newspaper Reports of "Juvenile Crimes" Ukyo Sakiyama ABSTRUCT The aim of this paper is to clarify the change of reports of juvenile crimes in newspaper. Juvenile crimes were treated as social
PubMedとは
7 1 PubMed 1994 4 1999 4 2004 4 7 PubMed PubMed http://www.ncbi.nlm.nih.gov/pubmed/ http://pubmed.gov National Library of Medicine; NLM PubMed NLM MEDLINE MEDLINE Index Medicus PubMed PubMed 1879 1964
日本職業・災害医学会会誌第51巻第5号
太田ら 同時多発性高血圧性脳葉出血の 1 手術例 図 1 搬入時 CT 上段 単純 CT 下段 造影 CT 図 2 術後の脳血管撮影検査では明らかな出血源は認めない 379 Reprint request: MULTIPLE SIMULTANEOUS HYPERTENSIVE LOBAR HEMORRHAGE Hirotsugu OHTA M.D. 1) and Akira YOKOTA M.D.
明海大学歯学雑誌 ３７‐２／１．秦泉寺
J Meikai Dent Med 37, 153 158, 8 153 1 7 5ml /1 min Wong-Baker Face Rating Scale FS 5 1 9. g 3 5ml /1 min, FS 1 66 6ml /1 min FS 5 1 9. g 3 6ml /1 min, FS 3 Two Cases of Xerostomia that Showed an Improvement
Key words : Adverse reactions, Egg allergy, IgG antibody, Mills allergy, FAST
Key words : Adverse reactions, Egg allergy, IgG antibody, Mills allergy, FAST 13) Danaeus, A., Johansson, S. G. O., Foucard, T. & Ohman, S.: Clinical and immunogical aspects of food allergy in childhood.
Comparative Study of Media Use Capacity for 8th Grade Students Yoshiro Kawakami Hirohisa Suzuki The world is experiencing a variety of changes resulting from the widespread diffusion of information technology.
2 146
28 2004 pp. 145 159 1 Received October 29, 2004 In 1999, North Korea reversed the negative economic growth of the 90s, and displayed a positive trend which, although weak, was maintained at 1.8% in 2003.
CASHLESSMEDICAL SERVICE I, the undersigned, hereby irrevocably authorize the Medical Service Providers to file a claim for and on behalf of me and/or
1 CASHLESSMEDICAL SERVICE I, the undersigned, hereby irrevocably authorize the Medical Service Providers to file a claim for and on behalf of me and/or the Insured Patient, for the costs of medical services
8 The Bulletin of Meiji University of Integrative Medicine API II 61 ASO X 11 7 X-4 6 X m 5 X-2 4 X 3 9 X 11 7 API 0.84 ASO X 1 1 MR-angio
7-14 2010 1 1 1 2 1 1 1 2 Fontaine II ASO61 3 API ASO ASO ASO API API KKKKKKKKKK ASO Fontaine II API Received April 14, 2009; Accepted July 16, 2009 I arteriosclerosis obliterans: ASO ASO 50 70 1,2 Fontaine